Abstract
Olecranon bursitis is a common condition that primarily affects men between the ages of 30 and 60. Although the conservative treatment of acutely inflamed olecranon bursitis is relatively straightforward, managing chronic olecranon bursitis can be challenging. In this publication, we report a case of rare bilateral chronic olecranon bursitis and discuss the rationale for choosing the best treatment option.
Keywords: chronic, bursitis, elbow swelling, elbow joint, olecranon
Introduction
Olecranon bursitis is a condition characterized by inflammation of the olecranon bursa, often resulting from microtrauma [1]. This condition accounts for 0.01-0.1% of hospital admissions and is more prevalent in males aged 30 to 60 [2]. Olecranon bursitis can be classified as acute or chronic and can also be either septic or non-septic [3]. Chronic bilateral olecranon bursitis is a rare but debilitating condition, especially for individuals engaged in repetitive manual labor, such as truck drivers.
Case presentation
A 73-year-old male truck driver presented to an outpatient clinic with a several-year history of progressively increasing bilateral elbow swelling. He reported no skin pain or pruritus and denied having fever, chills, weight loss, or gastrointestinal or respiratory symptoms. There was no notable travel history. He had a medical history of asthma and cirrhosis of the liver.
Physical examination revealed significant swelling overlying the olecranon processes of both elbows. The swellings were spherical, firm in consistency, and non-tender to palpation (Figures 1, 2). The patient reported frequent and repetitive pressure on both elbows while working. The swelling worsened after a long day of driving, especially if he had been forced to lean on his elbows for extended periods. Blood tests were within normal limits.
Figure 1. Left elbow with an olecranon bursitis mass.
Figure 2. Right elbow with an olecranon bursitis mass.
CT scan imaging of both elbows revealed bilateral soft tissue fluid-filled cystic masses consistent with chronically inflamed olecranon bursae. The left elbow bilobular mass measured 7.7 x 4.8 cm for the upper lobe and 8.4 x 7.5 x 5.5 cm for the lower lobe, while the right elbow mass measured 6.6 x 6.0 x 3.2 cm (Figures 3, 4).
Figure 3. CT scan axial view of both elbows showing bilateral soft tissue fluid-filled cystic masses.
Figure 4. CT scan sagittal view of both elbows showing bilateral soft tissue fluid-filled cystic masses.
Multiple trials of conservative treatments, including rest, regular icing of the affected areas, and analgesics as needed, failed to treat the inflamed bursae. Since the patient is a truck driver and the bursitis began to impact his work performance, surgical resection of the inflamed bursae was planned.
The patient was hospitalized, and surgical excision of both olecranon bursae was performed in the operating room under general anesthesia. The patient was positioned in the supine position, and an incision of the skin just above the bursae was made, followed by dissection of the subcutaneous tissues and removal of the fibrous and inflammatory tissues around the inflamed bursae (Figures 5, 6).
Figure 5. Exploration of the left elbow olecranon bursitis mass.
Figure 6. Exploration of the right elbow olecranon bursitis mass.
The masses were resected bilaterally and sent to the pathology laboratory (Figure 7). Hemostasis was achieved using electrocautery, and the skin was closed with non-absorbable suture material in a continuous fashion (Figure 8). Histopathologic examination of both elbows revealed chronic fibro-inflammatory changes of the resorptive granulomatous type, with no signs of malignancy or sepsis, consistent with chronic bilateral bursitis.
Figure 7. 15 cm measurement of the left elbow olecranon bursitis mass .
Figure 8. Left elbow post removal of the chronic bursitis mass.
The patient was then advised to follow a home exercise program to strengthen the muscles around the affected joints, reducing the risk of recurrence.
Follow-up over the next six months was uneventful, except for bilateral collections at the operation site on day 14 post-op. These collections were drained in the operating room under general anesthesia and were found to be hematomas. No postoperative complications occurred. The patient reported a full range of motion in both elbows with no signs of recurrent bursitis.
Discussion
Chronic bilateral olecranon bursitis is a rare condition with significant implications for patients engaged in repetitive manual labor, such as truck drivers. Treatments vary from conservative approaches like rest, ice, and analgesics to more invasive procedures like aspiration or surgical removal [4]. For chronic olecranon bursitis, symptomatic treatment involving elevation, splinting, ice, and anti-inflammatories is the preferred initial approach [5,6]. While aspiration and steroid injection into non-infected bursitis have been attempted to shorten the disease's course, some studies have challenged this approach, citing a 10% contamination risk leading to infection [7].
Surgical excision has been confirmed as an effective treatment for chronic olecranon bursitis unresponsive to conservative methods [5]. Other reasons for surgical removal include septic bursitis [8-12] and the presence of an olecranon spur [13].
In our practice, we emphasize the importance of rehabilitating the affected joints to prevent recurrence. A well-designed exercise regimen that includes regular stretching and strengthening exercises can be instrumental in avoiding further complications.
Conclusions
Treating chronic bilateral olecranon bursitis presents numerous challenges and varies depending on the specific circumstances. While conservative management is typically the first-line treatment, aspiration or surgical excision may be necessary in some cases. Rehabilitation of the affected joints is crucial for preventing recurrence.
Disclosures
Human subjects: Consent was obtained or waived by all participants in this study.
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:
Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.
Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.
Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Author Contributions
Concept and design: Ahmad Y. Nassar, Ahmad Srour, Youssef Abou Chahine, Bashour Hanna
Acquisition, analysis, or interpretation of data: Ahmad Y. Nassar, Mahmoud Ayche
Drafting of the manuscript: Ahmad Y. Nassar, Youssef Abou Chahine, Bashour Hanna, Mahmoud Ayche
Critical review of the manuscript for important intellectual content: Ahmad Y. Nassar, Ahmad Srour, Youssef Abou Chahine, Bashour Hanna
Supervision: Ahmad Y. Nassar, Ahmad Srour, Youssef Abou Chahine, Bashour Hanna
References
- 1.Clinical management of olecranon bursitis: a review. Nchinda NN, Wolf JM. J Hand Surg Am. 2021;46:501–506. doi: 10.1016/j.jhsa.2021.02.006. [DOI] [PubMed] [Google Scholar]
- 2.Diagnosis and management of olecranon bursitis. Del Buono A, Franceschi F, Palumbo A, Denaro V, Maffulli N. Surgeon. 2012;10:297–300. doi: 10.1016/j.surge.2012.02.002. [DOI] [PubMed] [Google Scholar]
- 3.Septic and non-septic olecranon bursitis in the accident and emergency department--an approach to management. Stell IM. J Accid Emerg Med. 1996;13:351–353. doi: 10.1136/emj.13.5.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Chronic olecranon bursitis. Herrera FA, Meals RA. J Hand Surg Am. 2011;36:708–709. doi: 10.1016/j.jhsa.2010.12.030. [DOI] [PubMed] [Google Scholar]
- 5.Treatment of olecranon bursitis: a systematic review. Sayegh ET, Strauch RJ. Arch Orthop Trauma Surg. 2014;134:1517–1536. doi: 10.1007/s00402-014-2088-3. [DOI] [PubMed] [Google Scholar]
- 6.Prepatellar and olecranon bursitis: literature review and development of a treatment algorithm. Baumbach SF, Lobo CM, Badyine I, Mutschler W, Kanz KG. Arch Orthop Trauma Surg. 2014;134:359–370. doi: 10.1007/s00402-013-1882-7. [DOI] [PubMed] [Google Scholar]
- 7.Olecranon bursitis: a systematic overview. Blackwell JR, Hay BA, Bolt AM, Hay SM. Shoulder Elbow. 2014;6:182–190. doi: 10.1177/1758573214532787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Complications following resection of the olecranon bursa. Degreef I, De Smet L. https://pubmed.ncbi.nlm.nih.gov/17009818/ Acta Orthop Belg. 2006;72:400–403. [PubMed] [Google Scholar]
- 9.Four common types of bursitis: diagnosis and management. Aaron DL, Patel A, Kayiaros S, Calfee R. J Am Acad Orthop Surg. 2011;19:359–367. doi: 10.5435/00124635-201106000-00006. [DOI] [PubMed] [Google Scholar]
- 10.A useful procedure in the treatment of chronic olecranon bursitis. Quayle J, Robinson M. Injury. 1977;9:299–302. doi: 10.1016/s0020-1383(77)80050-8. [DOI] [PubMed] [Google Scholar]
- 11.Predisposing factors, bacteriology and antibiotic therapy in 35 cases of septic bursitis. Söderquist B, Hedström SA. Scand J Infect Dis. 1986;18:305–311. doi: 10.3109/00365548609032341. [DOI] [PubMed] [Google Scholar]
- 12.Olecranon septic bursitis managed in an ambulatory setting. The Calgary Home Parenteral Therapy Program Study Group. Laupland KB, Davies HD. https://pubmed.ncbi.nlm.nih.gov/11558851/ Clin Invest Med. 2001;24:171–178. [PubMed] [Google Scholar]
- 13.Idiopathic or traumatic olecranon bursitis. Clinical features and bursal fluid analysis. Canoso JJ. Arthritis Rheum. 1977;20:1213–1216. doi: 10.1002/art.1780200609. [DOI] [PubMed] [Google Scholar]








